ID
44442
Descripción
This CRF is set up in modules to be used for recording data on the ISARIC COVID-19 Core Database or for independent studies. Module 1 and Module 2 complete on the first day of presentation/admission or on first day of COVID-19 assessment. Module 2 also complete on first day of admission to ICU or high dependency unit. In addition, complete daily for as many days as resources allow up to a maximum of 14 days. Continue to follow-up patients who transfer between wards. Module 3 (Outcome) complete at discharge or death General Guidance: - The CRF is designed to collect data obtained through examination, interview and review of hospital notes. Data may be collected retrospectively if the patient is enrolled after the admission date. - For more detailed guidance on how to complete these forms, please refer to the CRF Completion Guideline - Participant Identification Numbers consist of a 3 digit site code and a 4 digit participant number. You can obtain a site code and registering on the data management system by contacting ISARIC. Participant numbers should be assigned sequentially for each site beginning with 0001. In the case of a single site recruiting participants on different wards, or where it is otherwise difficult to assign sequential numbers, it is acceptable to assign numbers in blocks or incorporating alpha characters. E.g. Ward X will assign numbers from 0001 or A001 onwards and Ward Y will assign numbers from 5001 or B001 onwards. Enter the Participant Identification Number at the top of every page. - Printed paper CRFs may be used for later transfer of the data onto the electronic database. - For participants who return for re-admission to the same site, start a new form with a different Participant Identification Number. Please check “YES-admitted previously” in the ONSET & ADMISSION section. Enter as 2 separate entries in the electronic database. - For participants who transfer between two sites that are both collecting data on this form, it is preferred to have the data entered by a single site as a single admission, under the same Participant Identification Number. When this is not possible, the first site should record “Transfer to other facility” as an OUTCOME, and the second site should start a new form with a new patient number and indicate “YES-transferred” in ONSET & ADMISSION. - Complete every line of every section, except for where the instructions say to skip a section based on certain responses. - Mark ‘Not done’ for any results of laboratory values that are not available, not applicable or unknown. - Avoid recording data outside of the dedicated areas. Sections are available for recording additional information. - If using paper CRFs, we recommend writing clearly in ink, using BLOCK-CAPITAL LETTERS. - Place an (X) when you choose the corresponding answer. To make corrections, strike through (-------) the data you wish to delete and write the correct data above it. Please initial and date all corrections. - Please keep all of the sheets for a single participant together e.g. with a staple or participant-unique folder. - ISARIC would like the centers to enter data directly into their electronic data capture system. Please contact ISARIC about access. If your site would like to collect data independently, ISARIC can support you in the estabilishment of locally hosted databases. This version may serve as a basis for locally hosted databases. - Please contact ISARIC, if you need help with databases, have comments or to let ISARIC know that you are using the CRF. - Please let us know if you find any mistakes in the MDM Portal's version. FURTHER GUIDANCE AND DEFINITIONS (from the Completion guideline) Comorbidities: Comorbidities present before the onset of COVID-19 and are still present. Do not include those that developed following the onset of COVID-19 symptoms. More detailed guidance is provided. Hospital admission: For patients who were admitted to hospital with COVID-19 or symptoms consistent with possible COVID-19 infection, please enter details for the date of hospital admission. For patients with a clear alternative diagnosis leading to admission who subsequently acquired COVID-19, original admission date should be provided, but all subsequent references to admission should be taken as referring to day COVID-19 was first clinically suspected (or within the first 24 hours after first day of suspected or confirmed COVID-19 infection). Where a patient was admitted via multiple hospital departments, count admission from the time they came to the first department during the visit that led to their admission (e.g. arrival at the Emergency Department). Oxygen therapy: Include any form of supplemental oxygen received using any methods. Invasive ventilation: Please include any mechanical ventilation delivered following intubation or via a tracheostomy. Do not include patients who are breathing independently via a tracheostomy. Non-invasive ventilation: Please include any positive-pressure treatment given via a tight-fitted mask. This can be continuous positive pressure (CPAP) or bi-level positive pressure (BIPAP). Renal replacement therapy or dialysis: Please include any form of continuous renal replacement therapy or intermittent haemodialysis. Worst result: References to ‘worst result’ refer to those furthest from the normal physiological range or laboratory normal range. Results that were rejected by the clinical team (e.g. pulse oximetry on poorly perfused extremities, haemolysed blood samples, contaminated microbiology results) should not be reported. The following measures should be considered as a single observation and entered together: Blood gas results: Please report the measures from the blood gas with the lowest pH (most acidotic). Blood pressure: Please report the systolic and diastolic blood pressure from the observation with the lowest mean arterial pressure (if mean arterial pressure has not been calculated, report the measurement with lowest systolic blood pressure). Respiratory rate: If both abnormal low and high rate observed, record the abnormally high rate. General information about ISARIC ISARIC has developed a portfolio of resources to accelerate outbreak research and response. All resources are designed to address the most critical public health questions, have undergone extensive review by international clinical experts, and are free to use. ISARIC should be acknowledged and informed if you implement the protocol. Ethical apporval of the protocol and all necessary operational and financial arrangements are the responsibility of the investigators. This form refers to the CoV CASE RECORD FORM Version 1.3 25 Aug 2020. See https://isaric.tghn.org/COVID-19-CRF/
Link
https://isaric.tghn.org/COVID-19-CRF/
Palabras clave
Versiones (2)
- 18/1/21 18/1/21 -
- 20/9/21 20/9/21 -
Titular de derechos de autor
ISARIC on behalf of Oxford University
Subido en
20 de septiembre de 2021
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-SA 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
ISARIC/WHO Novel Coronavirus (nCoV) / COVID-19 Case Record Form
MODULE 3: OUTCOME CASE REPORT FORM
- StudyEvent: ODMjoin
Descripción
At ANY time during hospitalisation, did the patient receive/undergo:
Alias
- UMLS CUI-1
- C0087111
Descripción
Complete this field for all patients. If the patient received any form of supplementary oxygen, via nose cannula, mask or non-invasive or invasive ventilation tick ‘yes’ and indicate the total days they received any form of oxygen (O2) therapy. If any supplemental oxygen (at any concentration) was given by any means of delivery at any point during the patient’s hospital stay, place a cross in the box marked ‘yes’. This includes any supplementary oxygen (O2) delivered via non-invasive facemasks/nasal cannula/mask or via invasive mechanical ventilation. Please also indicate the maximum O2 flow volume. If it is not possible to access record of the absolute highest O2 volume delivered during the admission indicate the highest known.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0184633
Descripción
Complete this field for all patients. If the patient received any form of supplementary oxygen, via nose cannula, mask or non-invasive or invasive ventilation tick ‘yes’ and indicate the total days they received any form of oxygen (O2) therapy. If any supplemental oxygen (at any concentration) was given by any means of delivery at any point during the patient’s hospital stay, place a cross in the box marked ‘yes’. This includes any supplementary oxygen (O2) delivered via non-invasive facemasks/nasal cannula/mask or via invasive mechanical ventilation. Please also indicate the maximum O2 flow volume. If it is not possible to access record of the absolute highest O2 volume delivered during the admission indicate the highest known. For all questions of duration, please count the number of calendar days that the patient received the treatment. For treatments that were stopped and restarted, count those days on which the treatment was given but don’t count any calendar days on which it was not given at all.
Tipo de datos
integer
Unidades de medida
- days
Alias
- UMLS CUI [1,1]
- C0184633
- UMLS CUI [1,2]
- C0449238
- UMLS CUI [1,3]
- C2348235
Descripción
Complete this field for all patients. If the patient received any form of supplementary oxygen, via nose cannula, mask or non-invasive or invasive ventilation tick ‘yes’ and indicate the total days they received any form of oxygen (O2) therapy. If any supplemental oxygen (at any concentration) was given by any means of delivery at any point during the patient’s hospital stay, place a cross in the box marked ‘yes’. This includes any supplementary oxygen (O2) delivered via non-invasive facemasks/nasal cannula/mask or via invasive mechanical ventilation. Please also indicate the maximum O2 flow volume. If it is not possible to access record of the absolute highest O2 volume delivered during the admission indicate the highest known.
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0184633
- UMLS CUI [1,2]
- C0449238
- UMLS CUI [1,3]
- C0439673
Descripción
Maximum O2 flow volume
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C1960999
Descripción
If the patient received non-invasive ventilation (NIV), defined as the provision of ventilatory support through the patient's upper airway using a mask or similar device, at any time during their hospital stay, place tick ‘yes’ and enter the total duration in days if known.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C1997883
Descripción
If the patient received non-invasive ventilation (NIV), defined as the provision of ventilatory support through the patient's upper airway using a mask or similar device, at any time during their hospital stay, place tick ‘yes’ and enter the total duration in days if known. For all questions of duration, please count the number of calendar days that the patient received the treatment. For treatments that were stopped and restarted, count those days on which the treatment was given but don’t count any calendar days on which it was not given at all.
Tipo de datos
integer
Unidades de medida
- days
Alias
- UMLS CUI [1,1]
- C1997883
- UMLS CUI [1,2]
- C0449238
- UMLS CUI [1,3]
- C2348235
Descripción
If the patient received non-invasive ventilation (NIV), defined as the provision of ventilatory support through the patient's upper airway using a mask or similar device, at any time during their hospital stay, place tick ‘yes’ and enter the total duration in days if known.
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C1997883
- UMLS CUI [1,2]
- C0449238
- UMLS CUI [1,3]
- C0439673
Descripción
Invasive ventilation means that patient has undergone tracheal intubation, for the purpose of invasive mechanical ventilation. Invasive ventilation is a method to mechanically assist or replace spontaneous breathing in patients by use of a powered device that forces oxygenated air into the lungs. The mode of intubation may be orotracheal, nasotracheal, or via a cricothyrotomy or tracheotomy.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C1868981
Descripción
For all questions of duration, please count the number of calendar days that the patient received the treatment. For treatments that were stopped and restarted, count those days on which the treatment was given but don’t count any calendar days on which it was not given at all.
Tipo de datos
integer
Unidades de medida
- days
Alias
- UMLS CUI [1,1]
- C1868981
- UMLS CUI [1,2]
- C0449238
Descripción
Invasive ventilation means that patient has undergone tracheal intubation, for the purpose of invasive mechanical ventilation. Invasive ventilation is a method to mechanically assist or replace spontaneous breathing in patients by use of a powered device that forces oxygenated air into the lungs. The mode of intubation may be orotracheal, nasotracheal, or via a cricothyrotomy or tracheotomy.
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C1868981
- UMLS CUI [1,2]
- C0439673
Descripción
Prone ventilation refers to ventilation with the patient lying in the prone position. If the patient received prone ventilation at any time during their hospital stay, please tick ‘yes’ and indicate the total duration in days.
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0808387
- UMLS CUI [1,2]
- C0033422
Descripción
Prone ventilation refers to ventilation with the patient lying in the prone position. If the patient received prone ventilation at any time during their hospital stay, please tick ‘yes’ and indicate the total duration in days. For all questions of duration, please count the number of calendar days that the patient received the treatment. For treatments that were stopped and restarted, count those days on which the treatment was given but don’t count any calendar days on which it was not given at all.
Tipo de datos
integer
Unidades de medida
- days
Alias
- UMLS CUI [1,1]
- C0808387
- UMLS CUI [1,2]
- C0033422
- UMLS CUI [1,3]
- C0449238
- UMLS CUI [1,4]
- C2348235
Descripción
Prone ventilation refers to ventilation with the patient lying in the prone position. If the patient received prone ventilation at any time during their hospital stay, please tick ‘yes’ and indicate the total duration in days.
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0808387
- UMLS CUI [1,2]
- C0033422
- UMLS CUI [1,3]
- C0449238
- UMLS CUI [1,4]
- C0439673
Descripción
If the patient received inhaled nitric oxide at any time during their hospital stay, place a cross (X) in the box marked ‘yes’. If they did not, place a cross in the box marked ‘no’. If the answer is not known, place a cross in the box marked ‘N/A’.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C1135443
Descripción
If the patient received a tracheostomy, place a cross (X) in the box marked ‘yes’. If they did not, place a cross in the box marked ‘no’. If the answer is not known, place a cross in the box marked ‘N/A’.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0040590
Descripción
Extracorporeal Life Support (ECLS), also known as Extracorporeal membrane oxygenation (ECMO) is a variation of cardiopulmonary bypass, it maintains tissue oxygenation for days to weeks in patients with life threatening respiratory or cardiac failure (or both). N/A’).
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C4068956
Descripción
Extracorporeal Life Support (ECLS), also known as Extracorporeal membrane oxygenation (ECMO) is a variation of cardiopulmonary bypass, it maintains tissue oxygenation for days to weeks in patients with life threatening respiratory or cardiac failure (or both). N/A’). For all questions of duration, please count the number of calendar days that the patient received the treatment. For treatments that were stopped and restarted, count those days on which the treatment was given but don’t count any calendar days on which it was not given at all.
Tipo de datos
integer
Unidades de medida
- days
Alias
- UMLS CUI [1,1]
- C4068956
- UMLS CUI [1,2]
- C0449238
- UMLS CUI [1,3]
- C2348235
Descripción
Extracorporeal Life Support (ECLS), also known as Extracorporeal membrane oxygenation (ECMO) is a variation of cardiopulmonary bypass, it maintains tissue oxygenation for days to weeks in patients with life threatening respiratory or cardiac failure (or both). N/A’).
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C4068956
- UMLS CUI [1,2]
- C0439673
Descripción
Renal replacement therapy includes haemodialysis, peritoneal dialysis (PD), intermittent haemodialysis (IHD), on-line intermittent haemofiltration (IHF), on-line haemodiafiltration (IHDF), continuous haemofiltration (CHF) and continuous haemodiafiltration (CHDF), continuous venovenous haemofiltration (CVVH), continuous venovenous haemodialysis (CVVHD), continuous venovenous haemodiafiltration (CVVHDF), slow continuous ultrafiltration (SCUF), continuous arteriovenous haemofiltration (CAVHD) and sustained low- efficiency dialysis (SLED).
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0206074
- UMLS CUI [2]
- C0011946
Descripción
A vasopressor is a pharmaceutical agent that causes vasoconstriction. Agents include norepinephrine, epinephrine, vasopressin, terlipressin and phenylephrine. An inotrope is a pharmaceutical agent that alters the force of myocardial contractility. Commonly used ‘positive’ inotropes include dobutamine, dopamine, milrinone and adrenaline (epinephrine). If the patient received a vasopressor or inotrope for at least one hour during their hospital stay, place tick ‘yes’ and the total duration in days if known.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0304509
- UMLS CUI [2]
- C0042397
Descripción
A vasopressor is a pharmaceutical agent that causes vasoconstriction. Agents include norepinephrine, epinephrine, vasopressin, terlipressin and phenylephrine. An inotrope is a pharmaceutical agent that alters the force of myocardial contractility. Commonly used ‘positive’ inotropes include dobutamine, dopamine, milrinone and adrenaline (epinephrine). If the patient received a vasopressor or inotrope for at least one hour during their hospital stay, place tick ‘yes’ and the total duration in days if known. For all questions of duration, please count the number of calendar days that the patient received the treatment. For treatments that were stopped and restarted, count those days on which the treatment was given but don’t count any calendar days on which it was not given at all.
Tipo de datos
integer
Unidades de medida
- days
Alias
- UMLS CUI [1,1]
- C0042397
- UMLS CUI [1,2]
- C0449238
- UMLS CUI [1,3]
- C2348235
- UMLS CUI [2,1]
- C0304509
- UMLS CUI [2,2]
- C0449238
- UMLS CUI [2,3]
- C2348235
Descripción
A vasopressor is a pharmaceutical agent that causes vasoconstriction. Agents include norepinephrine, epinephrine, vasopressin, terlipressin and phenylephrine. An inotrope is a pharmaceutical agent that alters the force of myocardial contractility. Commonly used ‘positive’ inotropes include dobutamine, dopamine, milrinone and adrenaline (epinephrine). If the patient received a vasopressor or inotrope for at least one hour during their hospital stay, place tick ‘yes’ and the total duration in days if known.
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0304509
- UMLS CUI [1,2]
- C0439673
- UMLS CUI [2,1]
- C0042397
- UMLS CUI [2,2]
- C0439673
Descripción
Place a cross (X) in the appropriate box: yes, (if admitted) or no (if this is not the case).
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0583239
- UMLS CUI [2]
- C1301858
Descripción
Please enter the total number of days the patient was admitted to the ICU/HDU, this should include all ICU/HDU admissions if there were more than one. Count any day in which the patient was in ICU/HDU during that 24 hour period (please note this number could be significantly shorter than indicated by the two dates indicated in the first and last day field if the patient was discharged to another ward/unit and readmitted to the ICU/HDU during their hospital stay). For all questions of duration, please count the number of calendar days that the patient received the treatment. For treatments that were stopped and restarted, count those days on which the treatment was given but don’t count any calendar days on which it was not given at all.
Tipo de datos
integer
Unidades de medida
- days
Alias
- UMLS CUI [1,1]
- C1627345
- UMLS CUI [1,2]
- C0444921
- UMLS CUI [1,3]
- C2348235
- UMLS CUI [2,1]
- C0021708
- UMLS CUI [2,2]
- C0444921
- UMLS CUI [2,3]
- C2348235
Descripción
Please enter the total number of days the patient was admitted to the ICU/HDU, this should include all ICU/HDU admissions if there were more than one. Count any day in which the patient was in ICU/HDU during that 24 hour period (please note this number could be significantly shorter than indicated by the two dates indicated in the first and last day field if the patient was discharged to another ward/unit and readmitted to the ICU/HDU during their hospital stay).
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C1627345
- UMLS CUI [1,2]
- C0449238
- UMLS CUI [1,3]
- C0439673
- UMLS CUI [2,1]
- C0021708
- UMLS CUI [2,2]
- C0449238
- UMLS CUI [2,3]
- C0439673
Descripción
Date of most recent admission from ICU/ HDU. This section may need to be revised if the patient has more than one ICU/HDU admission during a single hospital admission.
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0583239
- UMLS CUI [1,2]
- C1302393
- UMLS CUI [2,1]
- C1301858
- UMLS CUI [2,2]
- C1302393
Descripción
If the answer is YES, please indicate the date on which the patient was first admitted to the intensive care unit / High Dependence Unit (ICU/HDU).
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0583239
- UMLS CUI [1,2]
- C1302393
- UMLS CUI [1,3]
- C0439673
- UMLS CUI [2,1]
- C1301858
- UMLS CUI [2,2]
- C1302393
- UMLS CUI [2,3]
- C0439673
Descripción
Date of most recent discharge from ICU/ HDU. This section may need to be revised if the patient has more than one ICU/HDU admission during a single hospital admission.
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C1627345
- UMLS CUI [1,2]
- C2361123
- UMLS CUI [2,1]
- C0021708
- UMLS CUI [2,2]
- C2361123
Descripción
Date of most recent discharge from ICU/ HDU. This section may need to be revised if the patient has more than one ICU/HDU admission during a single hospital admission.
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C1627345
- UMLS CUI [1,2]
- C2361123
- UMLS CUI [1,3]
- C0439673
- UMLS CUI [2,1]
- C0021708
- UMLS CUI [2,2]
- C2361123
- UMLS CUI [2,3]
- C0439673
Descripción
At any time during hospitalisation did the patient experience
Alias
- UMLS CUI-1
- C0009566
Descripción
Clinically or radiologically diagnosed viral pneumonitis/pneumonia. For all items in this group: Please select all that were clinically identified at any time during the hospital admission. Do not include known comorbidities (e.g. previous atrial fibrillation should not be included but new onset during this admission should). Record physician diagnosed complications.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0032310
Descripción
Clinically or radiologically diagnosed bacterial pneumonia (including community, hospital and ventilator acquired) managed with antimicrobials. Bacteriological confirmation not required.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0004626
Descripción
Defined according to Berlin criteria as: - Occurring within 1 week of a known clinical insult or worsening respiratory symptoms - Bilateral radiological opacities not fully explained by effusions, lobar/lung collapse, or nodules - Respiratory failure not fully explained by cardiac failure or fluid overload
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C4534309
Descripción
Defined according to Berlin criteria as: - Occurring within 1 week of a known clinical insult or worsening respiratory symptoms - Bilateral radiological opacities not fully explained by effusions, lobar/lung collapse, or nodules - Respiratory failure not fully explained by cardiac failure or fluid overload The severity of the hypoxaemia defines the severity of the ARDS: Mild ARDS: The PaO2/FiO2 is >200 mmHg, but ≤300 mmHg, on ventilator settings that include positive end- expiratory pressure (PEEP) or continuous positive airway pressure (CPAP) ≥5 cm H2O. Moderate ARDS: The PaO2/FiO2 is >100 mmHg, but ≤200 mmHg, on ventilator settings that include PEEP ≥5 cm H2O. Severe ARDS: The PaO2/FiO2 is ≤100 mmHg on ventilators setting that include PEEP ≥5 cm H2O. To determine the PaO2/FiO2 ratio, the PaO2 is measured in mmHg and the FiO2 is expressed as a decimal between 0.21 and 1. As an example, if a patient has a PaO2 of 60 mmHg while receiving 60% oxygen, then the PaO2/FiO2 is 60/0.6 = 100 mmHg.
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C4534309
- UMLS CUI [1,2]
- C0439793
Descripción
Is defined as the abnormal presence of air in the pleural cavity (between the lungs and the chest wall), causing collapse of the lung. It may be diagnosed clinically, usually with radiological confirmation.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0032326
Descripción
Is defined as increased amounts of fluid within the pleural cavity. It may be diagnosed clinically, with or without radiological or interventional confirmation.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C1253943
Descripción
Idiopathic diffuse interstitial lung disease, diagnosed radiologically (multiple consolidative or ground glass opacities) or histologically (granulation tissue and chronic inflammatory infiltrate in alveoli). Formerly known as bronchiolitis obliterans organizing pneumonia (BOOP)
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0242770
Descripción
This is a clinical diagnosis.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0006271
Descripción
Sudden cessation of cardiac activity with no normal breathing and no signs of circulation.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0018790
Descripción
Myocardial ischaemia (MI) leading to injury/necrosis, diagnosed by clinical findings, altered electrocardiography and elevated cardiac enzymes.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0027051
Descripción
Is defined as diminished blood and oxygen supply to the heart muscle, also known as myocardial ischemia, It is confirmed by an electrocardiogram (showing ischaemic changes, e.g. ST depression or elevation) and/or cardiac enzyme elevation.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0151744
Descripción
If a cardiac arrhythmia is identified and there is no previous record of it, select ‘yes’.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0003811
Descripción
Myocarditis / pericarditis refers to an inflammation of the heart or pericardium (outer lining of the heart). Diagnosis can be clinical, biochemical (cardiac enzymes) or radiological.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0027059
- UMLS CUI [2]
- C0031046
Descripción
Endocarditis is an inflammation of the endocardium (inner lining of the heart). Diagnosis is according to modified Duke criteria, using evidence from microbiological results, echocardiogram and clinical signs.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0014118
Descripción
Structural and functional disorders of myocardium commonly diagnosed by echocardiography. Can be primary (genetic) or secondary (e.g. following myocardial infarction).
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0878544
Descripción
Is defined as failure of the heart to pump a sufficient amount of blood to meet the needs of the body tissues, resulting in tissue congestion and oedema.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0018802
Descripción
Select ‘yes’ for any seizure regardless of cause (e.g. febrile or due to epilepsy)
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0036572
Descripción
Stroke may be a clinical diagnosis, with or without supportive radiological findings.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0038454
Descripción
Inflammation of the meninges or the brain parenchyma. Select yes if diagnosed clinically, radiologically or microbiologically.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0497299
Descripción
Growth of bacteria on a blood culture. Select ‘no’ if the only bacteria grown were believed to be skin contaminants (e.g. coagulase negative Staphylococci or diphtheroids).
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0004610
Descripción
Abnormal coagulation identified by abnormal prothrombin time or activated partial thromboplastin time. Disseminated intravascular coagulation (DIC; consumption coagulopathy; defibrination syndrome) is defined by thrombocytopenia, prolonged prothrombin time, low fibrinogen, elevated D-dimer and thrombotic microangiopathy.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0012739
- UMLS CUI [2]
- C0005779
Descripción
Obstruction of pulmonary artery by thrombus, air or fat. Physician diagnosis based on clinical signs, computed tomographic pulmonary angiography and/or ventilation/perfusion scanning.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0034065
Descripción
Select ‘yes’ if haemoglobin levels were lower than age- and sex-specific thresholds listed in https://media.tghn.org/medialibrary/2020/04/ISARIC_nCoV_CRF_Completion_Guide_V1.3_24Feb2020.pdf (Page 15 of 22)
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0002871
Descripción
Rhabdomyolysis is a syndrome characterised by muscle necrosis and the release of myoglobin into the blood. Muscle biopsy, electromyography, radiological imaging and the presence of myoglobinuria are not required for the diagnosis. Myositis may be a clinical diagnosis with supporting evidence from laboratory tests e.g. elevated serum creatine kinase; histological confirmation is not required to make the diagnosis. Myositis can occur without progression to rhabdomyolysis.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0035410
- UMLS CUI [2]
- C0027121
Descripción
Acute renal injury is defined as any of: - Increase in serum creatinine by ≥0.3 mg/dL (≥26.5 μmol/L) within 48 hours - Increase in serum creatinine to ≥1.5 times baseline, which is known or presumed to have occurred within the prior 7 days - Urine volume <0.5 mL/kg/hour for 6 hours
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0022660
- UMLS CUI [2]
- C2609414
Descripción
Refers to bleeding originating from any part of the gastrointestinal tract (from the oropharynx to the rectum).
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0017181
Descripción
Inflammation of the pancreas, diagnosed from clinical, biochemical, radiological or histological evidence.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0030305
Descripción
A finding that indicates abnormal liver function, may refer to any of the following: - Clinical jaundice - Hyperbilirubinaemia (blood bilirubin level twice the upper limit of the normal range) - An increase in alanine transaminase or aspartate transaminase that is twice the upper limit of the normal range
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0086565
Descripción
For adults, is defined as an abnormally high level of glucose in the blood, blood glucose level that is consistently above 126mg/dL or 7 mmol/L. For children, is defined as a blood glucose level consistently above 8.3 mmol/L.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0020456
Descripción
For adults, is defined as an abnormally low level of glucose in the blood, a blood glucose level that is consistently below 70mg/dL or 4 mmol/L. For children, is defined as a blood glucose level below 3 mmol/L.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0020615
Descripción
Please specify other complications in the space provided.
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0009566
- UMLS CUI [1,2]
- C0205394
Descripción
Other Complications Specification
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0205394
- UMLS CUI [1,2]
- C0009566
- UMLS CUI [1,3]
- C2348235
Descripción
Diagnostics
Alias
- UMLS CUI-1
- C0430022
Descripción
Please record if the patient was clinically diagnosed with COVID-19, even if resources did not allow testing or if laboratory results were negative but the clinician judged that based on symptoms, onset and clinical case definitions COVID-19 infection was the most likely cause of the symptoms experienced. Please complete all of the Diagnostics section even if results were negative, to monitor co-infection risk and rates.
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C5203670
- UMLS CUI [1,2]
- C0332140
Descripción
If laboratory testing was done, complete the section Select YES – Confirmed if the test was positive, Yes – Probable if there was a clinical diagnosis but no positive lab test and NO if the lab test was negative. If the lab test was not done or there is no clinical diagnosis please leave blank.
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0450254
- UMLS CUI [1,2]
- C0022885
- UMLS CUI [1,3]
- C0347984
- UMLS CUI [1,4]
- C0012634
- UMLS CUI [1,5]
- C1948053
Descripción
If patient diagnosed with COVID-19 either confirmed or probable per definition above mark an 'X' in the box for Novel CoV.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0206422
Descripción
If patient diagnosed with COVID-19 either confirmed or probable per definition above mark an 'X' in the box for Novel CoV.
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0206422
- UMLS CUI [1,2]
- C0449560
Descripción
Other Coronavirus Subtype
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0205394
- UMLS CUI [1,2]
- C0206422
- UMLS CUI [1,3]
- C0449560
- UMLS CUI [1,4]
- C2348235
Descripción
Influenza
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0021400
Descripción
Influenza subtype
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0021400
- UMLS CUI [1,2]
- C0449560
Descripción
Other Influenza subtype
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0021400
- UMLS CUI [1,2]
- C0449560
- UMLS CUI [1,3]
- C2348235
Descripción
RSV
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0035236
Descripción
Adenovirus
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0001483
Descripción
Bacteria
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0004611
Descripción
Bacteria specification
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0004611
- UMLS CUI [1,2]
- C2348235
- UMLS CUI [1,3]
- C0370003
Descripción
Bacteria specimen unknown
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0004611
- UMLS CUI [1,2]
- C2348235
- UMLS CUI [1,3]
- C0439673
Descripción
Other pathogen/s detected
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0205394
- UMLS CUI [1,2]
- C0450254
- UMLS CUI [1,3]
- C0243095
Descripción
Other pathogen/s detected - specification
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0205394
- UMLS CUI [1,2]
- C0450254
- UMLS CUI [1,3]
- C2348235
Descripción
Other pathogen/s detected - specimen unknown
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0205394
- UMLS CUI [1,2]
- C0450254
- UMLS CUI [1,3]
- C0370003
- UMLS CUI [1,4]
- C0439673
Descripción
Tick ‘yes’ f this was a Physician diagnosis.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0543829
Descripción
Record if X-ray and/or CT were performed, even if no infiltrates were present.
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0039985
- UMLS CUI [1,2]
- C0884358
Descripción
Chest X-Ray: infiltrates present
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C2073654
Descripción
Record if X-ray and/or CT were performed, even if no infiltrates were present.
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0040405
- UMLS CUI [1,2]
- C0884358
Descripción
CT performed: infiltrates present
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C2073654
Descripción
Biospecimen Testing
Alias
- UMLS CUI-1
- C2347026
- UMLS CUI-2
- C0022885
Descripción
Collection Date
Tipo de datos
date
Alias
- UMLS CUI [1]
- C1302413
Descripción
If the patient had samples taken for pathogen detection testing during their hospital stay, please complete a row for every type of sample collected (e.g. nasal/NP swab, sputum, etc.). Where both positive and negative results for a particular sample type exist (from samples taken at different time points during the patient’s hospital stay) please record the earliest positive result. If only multiple negative results exist for a particular sample type (from samples taken at different time points during the patient’s hospital stay), please document the earliest negative result.
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2347029
Descripción
Other Biospecimen Type
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0205394
- UMLS CUI [1,2]
- C2347029
- UMLS CUI [1,3]
- C2348235
Descripción
Laboratory test Method
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C2826902
Descripción
Other laboratory test method
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0205394
- UMLS CUI [1,2]
- C2826902
- UMLS CUI [1,3]
- C2348235
Descripción
Laboratory Test Result
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0587081
Descripción
Pathogen Tested/Detected
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0450254
- UMLS CUI [1,2]
- C1511790
Descripción
Medication: While hospitalised or at discharge, were any of the following administered? Antiviral therapy
Alias
- UMLS CUI-1
- C0280274
Descripción
Record all antivirals administered from date of admission or during the hospitalisation. Record the total number of days the treatment was given. For other antiviral or COVID-19 targeted agents record any medications given to treat COVID-19 that are not already pre-specified elsewhere in this section. Additional space is available under ‘Other treatments...’ at the end of this section if required.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0003451
- UMLS CUI [2,1]
- C5203670
- UMLS CUI [2,2]
- C2985566
Descripción
Antiviral agents administered
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0003451
- UMLS CUI [1,2]
- C2348235
- UMLS CUI [2,1]
- C5203670
- UMLS CUI [2,2]
- C2985566
- UMLS CUI [2,3]
- C2348235
Descripción
Other Antiviral agent
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0205394
- UMLS CUI [1,2]
- C0003451
Descripción
Antiviral agent - Start date
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0003451
- UMLS CUI [1,2]
- C0808070
Descripción
‘Antiviral Agent’ refers to any agent(s) prescribed to treat or prevent viral infections by interfering with the viral replication cycle. If the patient received antivirals at any time during their hospital stay, place a cross in the box marked ‘yes’ and also indicate the type of antiviral agent.
Tipo de datos
integer
Unidades de medida
- days
Alias
- UMLS CUI [1,1]
- C0003451
- UMLS CUI [1,2]
- C0449238
Descripción
Antiviral treatment duration unknown
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0003451
- UMLS CUI [1,2]
- C0449238
- UMLS CUI [1,3]
- C0439673
Descripción
Medication: While hospitalised or at discharge, were any of the following administered? Antibiotic therapy
Alias
- UMLS CUI-1
- C0338237
Descripción
‘Antibiotic’ refers to any agent(s) are substances naturally produced by microorganisms or their derivatives that selectively target microorganisms. These substances are used in the treatment of bacterial and other microbial infections. Topical preparations are not included.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0338237
Descripción
‘Antibiotic’ refers to any agent(s) are substances naturally produced by microorganisms or their derivatives that selectively target microorganisms. These substances are used in the treatment of bacterial and other microbial infections. Topical preparations are not included.
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0338237
Descripción
Antibiotic therapy - Date commenced
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C0338237
Descripción
Antibiotic therapy - duration
Tipo de datos
integer
Unidades de medida
- days
Alias
- UMLS CUI [1,1]
- C0338237
- UMLS CUI [1,2]
- C0449238
Descripción
Antibiotic therapy duration unknown
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0338237
- UMLS CUI [1,2]
- C0449238
- UMLS CUI [1,3]
- C0439673
Descripción
While hospitalised or at discharge, were any of the following administered? Corticosteriods
Alias
- UMLS CUI-1
- C0001617
Descripción
‘Corticosteroids’ (commonly referred to as ‘steroids’) refers to all types of therapeutic corticosteroid, made in the adrenal cortex (the outer part of the adrenal gland). They are also made in the laboratory. Examples include: prednisolone, prednisone, methyl- prednisolone, dexamethasone, hydrocortisone, fluticasone, betamethasone (note that other examples exist). Topical preparations are not included, but inhaled preparations are included. The indication for administering corticosteroids does not need to be directly related to the treatment of COVID-19.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0239126
Descripción
Corticosteroid: oral route of administration
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C1527415
- UMLS CUI [1,2]
- C0239126
Descripción
Corticosteroid: intravenous route of administration
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0239126
- UMLS CUI [1,2]
- C1522726
Descripción
Corticosteroid: inhaled route of administration
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0586793
Descripción
Corticosteroid: unknown route of administration
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0239126
- UMLS CUI [1,2]
- C1521803
Descripción
Oral oder IV Corticosteroid: agent
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1527415
- UMLS CUI [1,2]
- C0149783
- UMLS CUI [1,3]
- C2348235
- UMLS CUI [2,1]
- C0149783
- UMLS CUI [2,2]
- C2348235
- UMLS CUI [2,3]
- C1621368
Descripción
Oral oder IV Corticosteroid: dosage and unit
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1527415
- UMLS CUI [1,2]
- C0239126
- UMLS CUI [1,3]
- C0806909
- UMLS CUI [1,4]
- C2348070
- UMLS CUI [2,1]
- C0239126
- UMLS CUI [2,2]
- C1621368
- UMLS CUI [2,3]
- C0806909
- UMLS CUI [2,4]
- C2348070
- UMLS CUI [3,1]
- C1527415
- UMLS CUI [3,2]
- C0239126
- UMLS CUI [3,3]
- C2348328
- UMLS CUI [4,1]
- C0239126
- UMLS CUI [4,2]
- C1621368
- UMLS CUI [4,3]
- C2348328
Descripción
Corticosteroid - Start date
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C0149783
Descripción
Corticosteroid - Start date unknown
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C0149783
- UMLS CUI [1,3]
- C0439673
Descripción
Corticosteroid therapy duration
Tipo de datos
integer
Unidades de medida
- days
Alias
- UMLS CUI [1,1]
- C0149783
- UMLS CUI [1,2]
- C0449238
Descripción
Corticosteroid therapy duration unknown
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0449238
- UMLS CUI [1,2]
- C0149783
- UMLS CUI [1,3]
- C0439673
Descripción
Medication: While hospitalised or at discharge, were any of the following administered? Heparin
Alias
- UMLS CUI-1
- C0019134
Descripción
Heparin
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0019134
- UMLS CUI [1,2]
- C1533734
Descripción
Heparin - Subcutaneous route of administration
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0019134
- UMLS CUI [1,2]
- C1522438
Descripción
Heparin - Intravenous (IV) route of administration
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0019134
- UMLS CUI [1,2]
- C1522726
Descripción
Heparin - unknown route of administration
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0019134
- UMLS CUI [1,2]
- C1521803
Descripción
Unfractionated heparin
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C2825026
Descripción
Heparin type - Low molecular weight
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0019139
Descripción
Fondaparinux
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C1098510
Descripción
Heparin type unknown
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0332307
- UMLS CUI [1,2]
- C0019134
- UMLS CUI [1,3]
- C0439673
Descripción
Heparin dosage and unit
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0806909
- UMLS CUI [1,2]
- C2348070
- UMLS CUI [1,3]
- C0019134
- UMLS CUI [2,1]
- C2348328
- UMLS CUI [2,2]
- C0019134
Descripción
Heparin - Start date
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C0019134
Descripción
Heparin - Start date unknown
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C0019134
- UMLS CUI [1,3]
- C0439673
Descripción
Heparin therapy duration
Tipo de datos
integer
Unidades de medida
- days
Alias
- UMLS CUI [1,1]
- C0449238
- UMLS CUI [1,2]
- C0019134
Descripción
Heparin therapy duration unknown
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0449238
- UMLS CUI [1,2]
- C0019134
- UMLS CUI [1,3]
- C0439673
Descripción
Medication: While hospitalised or at discharge, were any of the following administered? Antifungal therapy
Alias
- UMLS CUI-1
- C0678026
Descripción
‘Antifungal agent’ refers to any agent(s) prescribed specifically to treat systemic or topical infections caused by fungi. Examples include fluconazole, amphotericin, caspofungin, anidulafungin, posaconazole, itraconazole (note that other examples exist). Topical preparations should not be recorded.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0003308
Descripción
Medication: While hospitalised or at discharge, were any of the following administered? Other treatments administered for COVID-19
Alias
- UMLS CUI-1
- C5203670
- UMLS CUI-2
- C0205394
- UMLS CUI-3
- C0013227
Descripción
Record any other medications, experimental or re-purposed, administered to modify the course of COVID-19 during the admission (including as part of a clinical trial). This could include convalescent plasma, immuno-modulatory agents and anti-viral agents not already recorded above.
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C5203670
- UMLS CUI [1,2]
- C0205394
- UMLS CUI [1,3]
- C0013227
- UMLS CUI [2,1]
- C0304229
- UMLS CUI [2,2]
- C5203670
- UMLS CUI [3,1]
- C0013227
- UMLS CUI [3,2]
- C2718016
- UMLS CUI [3,3]
- C5203670
Descripción
Other treatments administered for COVID-19
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C5203670
- UMLS CUI [1,2]
- C0205394
- UMLS CUI [1,3]
- C0013227
Descripción
Other treatment for COVID-19: dosage and unit
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C5203670
- UMLS CUI [1,2]
- C0205394
- UMLS CUI [1,3]
- C0013227
- UMLS CUI [1,4]
- C0806909
- UMLS CUI [1,5]
- C2348070
- UMLS CUI [2,1]
- C5203670
- UMLS CUI [2,2]
- C0205394
- UMLS CUI [2,3]
- C0013227
- UMLS CUI [2,4]
- C2348328
Descripción
Other treatment for COVID-19: Date of commencement
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C5203670
- UMLS CUI [1,2]
- C0205394
- UMLS CUI [1,3]
- C0013227
- UMLS CUI [1,4]
- C0808070
Descripción
Other treatment for COVID-19: Date of commencement known
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C5203670
- UMLS CUI [1,2]
- C0205394
- UMLS CUI [1,3]
- C0013227
- UMLS CUI [1,4]
- C0808070
- UMLS CUI [1,5]
- C0439673
Descripción
Other treatment for COVID-19: Duration of therapy
Tipo de datos
integer
Unidades de medida
- days
Alias
- UMLS CUI [1,1]
- C5203670
- UMLS CUI [1,2]
- C0205394
- UMLS CUI [1,3]
- C0013227
- UMLS CUI [1,4]
- C0449238
Descripción
Other treatment for COVID-19: Duration of therapy known
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C5203670
- UMLS CUI [1,2]
- C0205394
- UMLS CUI [1,3]
- C0013227
- UMLS CUI [1,4]
- C0449238
Descripción
Outcome
Alias
- UMLS CUI-1
- C1547647
Descripción
Discharged alive can mean discharge to their usual place of residence before their illness, to the home of a relative or friend, or to a social care facility, because their illness is no longer severe enough to warrant treatment in a medical facility. Hospitalized means they are still in hospital but have recovered from COVID-19 infection and the form has been completed as the patient is in a part of the hospital for care of other conditions and where the form will not be completed at a later date. Transfer to other facility means they have been transferred to another facility that provides medical care. This could be a specialist centre for more intensive treatment or a step-down for rehabilitation. It does not include facilities that solely provide social care (these patients should be listed as discharged alive). Death means the patient died in the hospital. Palliative discharge means the patient has been discharged with the expectation that they will not recover from this or other co-existing illness. This could be to a specialist hospice facility, or to their usual home address with anticipatory end of life medications.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C1547647
Descripción
Please state the date for the outcome listed above.
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C1547647
- UMLS CUI [1,2]
- C0011008
Descripción
Please state the date for the outcome listed above.
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C1547647
- UMLS CUI [1,2]
- C0011008
- UMLS CUI [1,3]
- C0439673
Descripción
Ability to self-care at discharge versus before illness: the patient is able to care for themselves at discharge (in terms of activities of daily living) at the same level as before they developed illness then tick ‘same as before illness’. If their ability to self-care has decreased or increased, then tick the appropriate circle (‘worse’ or ‘better’).
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0562734
- UMLS CUI [1,2]
- C3871203
Descripción
(Complete this section only if the patient is alive) Oxygen therapy includes, NIV or home ventilation (respiratory support/treatment).
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0586003
- UMLS CUI [1,2]
- C0687676
- UMLS CUI [1,3]
- C0184633
Similar models
MODULE 3: OUTCOME CASE REPORT FORM
- StudyEvent: ODMjoin
C0449238 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
C0449238 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C0449238 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
C0449238 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C0449238 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,2])
C0033422 (UMLS CUI [1,2])
C0033422 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,4])
C0033422 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
C0439673 (UMLS CUI [1,4])
C0449238 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
C0439673 (UMLS CUI [1,2])
C0011946 (UMLS CUI [2])
C0042397 (UMLS CUI [2])
C0449238 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
C0304509 (UMLS CUI [2,1])
C0449238 (UMLS CUI [2,2])
C2348235 (UMLS CUI [2,3])
C0439673 (UMLS CUI [1,2])
C0042397 (UMLS CUI [2,1])
C0439673 (UMLS CUI [2,2])
C1301858 (UMLS CUI [2])
C0444921 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
C0021708 (UMLS CUI [2,1])
C0444921 (UMLS CUI [2,2])
C2348235 (UMLS CUI [2,3])
C0449238 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C0021708 (UMLS CUI [2,1])
C0449238 (UMLS CUI [2,2])
C0439673 (UMLS CUI [2,3])
C1302393 (UMLS CUI [1,2])
C1301858 (UMLS CUI [2,1])
C1302393 (UMLS CUI [2,2])
C1302393 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C1301858 (UMLS CUI [2,1])
C1302393 (UMLS CUI [2,2])
C0439673 (UMLS CUI [2,3])
C2361123 (UMLS CUI [1,2])
C0021708 (UMLS CUI [2,1])
C2361123 (UMLS CUI [2,2])
C2361123 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C0021708 (UMLS CUI [2,1])
C2361123 (UMLS CUI [2,2])
C0439673 (UMLS CUI [2,3])
C0439793 (UMLS CUI [1,2])
C0031046 (UMLS CUI [2])
C0005779 (UMLS CUI [2])
C0027121 (UMLS CUI [2])
C2609414 (UMLS CUI [2])
C0205394 (UMLS CUI [1,2])
C0009566 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
C0332140 (UMLS CUI [1,2])
C0022885 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C0012634 (UMLS CUI [1,4])
C1948053 (UMLS CUI [1,5])
C0449560 (UMLS CUI [1,2])
C0206422 (UMLS CUI [1,2])
C0449560 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,4])
C0449560 (UMLS CUI [1,2])
C0449560 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,2])
C0370003 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C0450254 (UMLS CUI [1,2])
C0243095 (UMLS CUI [1,3])
C0450254 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
C0450254 (UMLS CUI [1,2])
C0370003 (UMLS CUI [1,3])
C0439673 (UMLS CUI [1,4])
C0884358 (UMLS CUI [1,2])
C2347029 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
C2826902 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
C1511790 (UMLS CUI [1,2])
C5203670 (UMLS CUI [2,1])
C2985566 (UMLS CUI [2,2])
C2348235 (UMLS CUI [1,2])
C5203670 (UMLS CUI [2,1])
C2985566 (UMLS CUI [2,2])
C2348235 (UMLS CUI [2,3])
C0003451 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C0338237 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C0239126 (UMLS CUI [1,2])
C1522726 (UMLS CUI [1,2])
C1521803 (UMLS CUI [1,2])
C0149783 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
C0149783 (UMLS CUI [2,1])
C2348235 (UMLS CUI [2,2])
C1621368 (UMLS CUI [2,3])
C0239126 (UMLS CUI [1,2])
C0806909 (UMLS CUI [1,3])
C2348070 (UMLS CUI [1,4])
C0239126 (UMLS CUI [2,1])
C1621368 (UMLS CUI [2,2])
C0806909 (UMLS CUI [2,3])
C2348070 (UMLS CUI [2,4])
C1527415 (UMLS CUI [3,1])
C0239126 (UMLS CUI [3,2])
C2348328 (UMLS CUI [3,3])
C0239126 (UMLS CUI [4,1])
C1621368 (UMLS CUI [4,2])
C2348328 (UMLS CUI [4,3])
C0149783 (UMLS CUI [1,2])
C0149783 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C0449238 (UMLS CUI [1,2])
C0149783 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C1522438 (UMLS CUI [1,2])
C1522726 (UMLS CUI [1,2])
C1521803 (UMLS CUI [1,2])
C0019134 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C2348070 (UMLS CUI [1,2])
C0019134 (UMLS CUI [1,3])
C2348328 (UMLS CUI [2,1])
C0019134 (UMLS CUI [2,2])
C0019134 (UMLS CUI [1,2])
C0019134 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C0019134 (UMLS CUI [1,2])
C0019134 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C0205394 (UMLS CUI-2)
C0013227 (UMLS CUI-3)
C0205394 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C0304229 (UMLS CUI [2,1])
C5203670 (UMLS CUI [2,2])
C0013227 (UMLS CUI [3,1])
C2718016 (UMLS CUI [3,2])
C5203670 (UMLS CUI [3,3])
C0205394 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C0806909 (UMLS CUI [1,4])
C2348070 (UMLS CUI [1,5])
C5203670 (UMLS CUI [2,1])
C0205394 (UMLS CUI [2,2])
C0013227 (UMLS CUI [2,3])
C2348328 (UMLS CUI [2,4])
C0205394 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C0808070 (UMLS CUI [1,4])
C0205394 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C0808070 (UMLS CUI [1,4])
C0439673 (UMLS CUI [1,5])
C0205394 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C0449238 (UMLS CUI [1,4])
C0205394 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C0449238 (UMLS CUI [1,4])
C0011008 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C3871203 (UMLS CUI [1,2])
C0687676 (UMLS CUI [1,2])
C0184633 (UMLS CUI [1,3])